Microbe Profile: - a Master of Deception

Overview

Journal Microbiology (Reading)

Specialty Microbiology

Date 2024 Nov 26

PMID 39589236

Authors

Maria Granada

Emily Cook

Gavin Sherlock

Frank Rosenzweig

Affiliations

Soon will be listed here.

Abstract

is a fungal microbe associated with multiple vertebrate microbiomes and their terrestrial environments. In humans, the species has emerged as an opportunistic pathogen that now ranks as the second-leading cause of candidiasis in Europe and North America (Beardsley . 2024, 62). People at highest risk of infection include the elderly, immunocompromised individuals and/or long-term residents of hospital and assisted-living facilities. is intrinsically drug-resistant, metabolically versatile and able to avoid detection by the immune system. Analyses of its 12.3 Mb genome indicate a stable pangenome Marcet-Houben . ( 2022, 20) and phylogenetic affinity with . Recent phylogenetic analyses suggest reclassifying as Lakashima and Sugita ( 2022, 63: 119-132).

Citing Articles

(Somm. et Levier) Manden.-A Comprehensive Phytochemical and Biological Evaluation.

Nersezashvili M, Berashvili D, Jokhadze M, Metreveli M, Swiatek L, Salwa K Molecules. 2025; 30(3).

PMID: 39942828 PMC: 11820956. DOI: 10.3390/molecules30030725.

References

Gale A, Pavesic M, Nickels T, Xu Z, Cormack B, Cunningham K . Redefining pleiotropic drug resistance in a pathogenic yeast: Pdr1 functions as a sensor of cellular stresses in . mSphere. 2023; 8(4):e0025423. PMC: 10449514. DOI: 10.1128/msphere.00254-23. View

Kumar K, Askari F, Sahu M, Kaur R . : A Lot More Than Meets the Eye. Microorganisms. 2019; 7(2). PMC: 6407134. DOI: 10.3390/microorganisms7020039. View

Cormack B, Falkow S . Efficient homologous and illegitimate recombination in the opportunistic yeast pathogen Candida glabrata. Genetics. 1999; 151(3):979-87. PMC: 1460538. DOI: 10.1093/genetics/151.3.979. View

Rasheed M, Battu A, Kaur R . Aspartyl proteases in are required for suppression of the host innate immune response. J Biol Chem. 2018; 293(17):6410-6433. PMC: 5925793. DOI: 10.1074/jbc.M117.813741. View

Kaur R, Domergue R, Zupancic M, Cormack B . A yeast by any other name: Candida glabrata and its interaction with the host. Curr Opin Microbiol. 2005; 8(4):378-84. DOI: 10.1016/j.mib.2005.06.012. View

Beardsley J, Kim H, Dao A, Kidd S, Alastruey-Izquierdo A, Sorrell T . Candida glabrata (Nakaseomyces glabrata): A systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens List. Med Mycol. 2024; 62(6). PMC: 11210615. DOI: 10.1093/mmy/myae041. View

Marcet-Houben M, Alvarado M, Ksiezopolska E, Saus E, de Groot P, Gabaldon T . Chromosome-level assemblies from diverse clades reveal limited structural and gene content variation in the genome of Candida glabrata. BMC Biol. 2022; 20(1):226. PMC: 9548116. DOI: 10.1186/s12915-022-01412-1. View

Kasper L, Seider K, Gerwien F, Allert S, Brunke S, Schwarzmuller T . Identification of Candida glabrata genes involved in pH modulation and modification of the phagosomal environment in macrophages. PLoS One. 2014; 9(5):e96015. PMC: 4006850. DOI: 10.1371/journal.pone.0096015. View

Dujon B, Sherman D, Fischer G, Durrens P, Casaregola S, Lafontaine I . Genome evolution in yeasts. Nature. 2004; 430(6995):35-44. DOI: 10.1038/nature02579. View

10.

Kaur R, Ma B, Cormack B . A family of glycosylphosphatidylinositol-linked aspartyl proteases is required for virulence of Candida glabrata. Proc Natl Acad Sci U S A. 2007; 104(18):7628-33. PMC: 1863504. DOI: 10.1073/pnas.0611195104. View

11.

Nikolov V, Malavia D, Kubota T . SWI/SNF and the histone chaperone Rtt106 drive expression of the Pleiotropic Drug Resistance network genes. Nat Commun. 2022; 13(1):1968. PMC: 9005695. DOI: 10.1038/s41467-022-29591-z. View

12.

Kumar K, Pareek A, Kaur R . SWI/SNF complex-mediated chromatin remodeling in promotes immune evasion. iScience. 2024; 27(4):109607. PMC: 11022050. DOI: 10.1016/j.isci.2024.109607. View

13.

Angoulvant A, Guitard J, Hennequin C . Old and new pathogenic Nakaseomyces species: epidemiology, biology, identification, pathogenicity and antifungal resistance. FEMS Yeast Res. 2015; 16(2):fov114. DOI: 10.1093/femsyr/fov114. View

14.

Kasper L, Seider K, Hube B . Intracellular survival of Candida glabrata in macrophages: immune evasion and persistence. FEMS Yeast Res. 2015; 15(5):fov042. DOI: 10.1093/femsyr/fov042. View

15.

Duxbury S, Bates S, Beardmore R, Gudelj I . Evolution of drug-resistant and virulent small colonies in phenotypically diverse populations of the human fungal pathogen . Proc Biol Sci. 2020; 287(1931):20200761. PMC: 7423662. DOI: 10.1098/rspb.2020.0761. View

16.

Al-Yasiri M, Normand A, LOllivier C, Lachaud L, Bourgeois N, Rebaudet S . Opportunistic fungal pathogen Candida glabrata circulates between humans and yellow-legged gulls. Sci Rep. 2016; 6:36157. PMC: 5080578. DOI: 10.1038/srep36157. View

17.

Takashima M, Sugita T . Taxonomy of Pathogenic Yeasts Candida, Cryptococcus, Malassezia, and Trichosporon. Med Mycol J. 2022; 63(4):119-132. DOI: 10.3314/mmj.22.004. View

18.

Badrane H, Cheng S, Dupont C, Hao B, Driscoll E, Morder K . Genotypic diversity and unrecognized antifungal resistance among populations of Candida glabrata from positive blood cultures. Nat Commun. 2023; 14(1):5918. PMC: 10516878. DOI: 10.1038/s41467-023-41509-x. View

19.

Seider K, Brunke S, Schild L, Jablonowski N, Wilson D, Majer O . The facultative intracellular pathogen Candida glabrata subverts macrophage cytokine production and phagolysosome maturation. J Immunol. 2011; 187(6):3072-86. DOI: 10.4049/jimmunol.1003730. View

20.

Gabaldon T, Fairhead C . Genomes shed light on the secret life of Candida glabrata: not so asexual, not so commensal. Curr Genet. 2018; 65(1):93-98. PMC: 6342864. DOI: 10.1007/s00294-018-0867-z. View